Brazil is a country with a high prevalence of infectious diseases such as leprosy and leishmaniasis. However, coinfection of these diseases is still poorly understood. We report a case of a patient who presented with lepromatous leprosy and cutaneous-mucosal leishmaniasis at the same period. After clinical, laboratory, and histopathological diagnosis, the treatment was introduced and the patient showed important clinical improvement. He was followed in our outpatient clinic. Both pathologies play an important role in the immune system. Depending on the immune response profile of the host, diseases may present themselves in different ways. In this case, the patient showed a divergent immune response for each disease. We hypothesized that this response is specific for each pathogen.
INTRODUCTION
Lepromatous leprosy (LL) and American cutaneous leishmaniasis (ACL) are diseases caused by intracellular microorganisms that affect the mucocutaneous tissue, with a chronic inflammatory response and a broad clinical spectrum. 1 They are of great importance in world public health and are highly prevalent in tropical countries, especially in Brazil.¹ Despite this, only a few cases have been reported with the association of both diseases.² LL is a chronic infectious disease caused by a bacillus known as Mycobacterium leprae. 1, 3 According to the WHO, more than 200,000 new cases are reported per year worldwide. In the Americas, Brazil holds 90% of the cases. 1 The clinical picture initially involves peripheral skin and nerves, with a possible evolution to deformities and physical disabilities. 3 Unlike LL, ACL is not contagious. 1, 4 It is caused by a protozoan parasite of the genus Leishmania, transmitted by sandflies. 4 Worldwide, its incidence is estimated at 0. The present report aims to describe a case of coinfection of LL and ACL, a picture with few reports in the literature. A pentavalent antimonial was then introduced at a dose of 15mg/ kg/day, intravenously, with significant clinical improvement of the two diseases. The patient is currently being followed up at the dermatology outpatient clinic.
CASE REPORT

DISCUSSION
The diseases described in the present study have a fundamental immunological role and their characteristics will depend on the intensity of the cell-mediated specific immunity expressed by the subject. Both may have an immune response mediated by T helper 1 (Th1) or T helper 2 (Th2) cells. In the present case, the patient presented with concomitant lepromatous leprosy and localized cutaneous leishmaniasis with different immune responses to each disease (anergic to the former and hyperergic to the latter) in the same period, suggesting that his immunological defect is specific for each infecting microorganism. 8 The association between LL and ACL is still little known, partially because this association is uncommon. Additional studies are needed to better explain the immunological mechanisms during the co-infection, aiming at the best treatment and avoiding the appearance of physical incapacities and sequelae that may be caused by these diseases. q
